George Bickerstaff, Co-Founder, and MD, MM Dillon
George Bickerstaff is co-founder and Managing Director of M.M.
“The biggest successes I’ve had really did come out from failures!”
Today on The Brand Called You, we have with us a very senior professional from the finance sector of the US, Mr. George Bickerstaff. George is the Co-Founder and Managing Director of MM Dillon. He is the Founder of the Global Leaders Network. George has also been the Chief Financial Officer of Novartis. He is a board member of several public companies. And is Chairman of the International Vaccine Institution in Seoul? George is also the Vice Chairman of the International Centre for Missing and Exploited Children. In this interview with host Asutosh Garg, George shares his life story, his experiences, and his professional journey. He begins by sharing the three key milestones of his life and why he holds them so important. George further goes on to talk about his role as an entrepreneur in the finance field. He speaks about the metrics of making an investment and also gives some tips for businesses to make the right investments. George and Ashutosh discuss the basic mistakes startup entrepreneurs make and the importance of having Co-Founders. George believes that entrepreneurs should be conscious risk-takers and keep learning from their failures. The interview also covers some very interesting discussions around networking, social media, and board assessments. In the end, George also shares his success mantra and some worthwhile advice to the youngsters!
George Bickerstaff is co-founder and Managing Director of M.M. Dillon, an investment bank serving healthcare and technology clients. Prior to M.M. Dillon, George had a successful career as a corporate executive, most recently as Chief Financial Officer of Novartis Pharma AG in Switzerland and previously as CFO of IMS Healthcare. George has been a board member of more than twenty global companies and foundations, frequently chairing the board or keyboard committees. His recent public boards include Ariad Pharmaceuticals, Axovant Sciences, Cardax, CareDx, Innoviva, and Inovio Pharmaceuticals. George’s philanthropic interests are in global healthcare and child protection. He currently serves as Chairman of the International Vaccine Institute in Seoul, South Korea, and Vice Chairman of the International Centre for Missing and Exploited Children in Washington, DC. George holds degrees in engineering and business and founded The Global Leaders network.
Chairman Of The Board
December 2017 – Present (3 years 3 months)
San Francisco Bay Area
Innoviva, Inc. is a publicly traded company that engages in the development and commercialization of pharmaceuticals.
International Vaccine Institute
Chairman Of The Board
January 2009 – Present (12 years 2 months)
Gwanak-gu, Seoul, Korea
The International Vaccine Institute develops vaccines for people in the world’s poorest countries.